Intracerebroventricular injection of glucagon-like peptide-1 changes lipid metabolism in chicks. 2007

Tetsuya Tachibana, and Daichi Oikawa, and Nami Adachi, and Tim Boswell, and Mitsuhiro Furuse
Laboratory of Advanced Animal and Marine Bioresources, Graduate School of Bioresource and Bioenvironmental Sciences, Kyushu University, Fukuoka 812-8581, Japan. tetsu@agr.ehime-u.ac.jp

Glucagon-like peptide-1 (GLP-1), derived from proglucagon, is thought to act as a negative regulator of energy homeostasis in mammals, since intracerebroventricular (ICV) injection of GLP-1 inhibits feeding behavior and enhances energy expenditure. The anorexigenic effect of GLP-1 is also observed in chicks, but whether brain GLP-1 enhances energy expenditure has not been investigated. The aim of the present study was to clarify the effect of ICV injection of GLP-1 on energy expenditure as well as metabolic changes in chicks. The injection of GLP-1 did not affect energy expenditure calculated from oxygen consumption and carbon dioxide production. On the other hand, the injection of GLP-1 significantly decreased respiratory quotient, suggesting that brain GLP-1 shifted the use of energy sources from carbohydrates to lipids. In support of this, ICV injection of GLP-1 increased plasma non-esterified fatty acid concentration while plasma glucose concentration was decreased. In conclusion, GLP-1 appears to act in the brain as a metabolic modulator rather than as a regulator of total energy expenditure in chicks.

UI MeSH Term Description Entries
D007276 Injections, Intraventricular Injections into the cerebral ventricles. Intraventricular Injections,Injection, Intraventricular,Intraventricular Injection
D008297 Male Males
D010101 Oxygen Consumption The rate at which oxygen is used by a tissue; microliters of oxygen STPD used per milligram of tissue per hour; the rate at which oxygen enters the blood from alveolar gas, equal in the steady state to the consumption of oxygen by tissue metabolism throughout the body. (Stedman, 25th ed, p346) Consumption, Oxygen,Consumptions, Oxygen,Oxygen Consumptions
D012119 Respiration The act of breathing with the LUNGS, consisting of INHALATION, or the taking into the lungs of the ambient air, and of EXHALATION, or the expelling of the modified air which contains more CARBON DIOXIDE than the air taken in (Blakiston's Gould Medical Dictionary, 4th ed.). This does not include tissue respiration ( Breathing
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D002245 Carbon Dioxide A colorless, odorless gas that can be formed by the body and is necessary for the respiration cycle of plants and animals. Carbonic Anhydride,Anhydride, Carbonic,Dioxide, Carbon
D002645 Chickens Common name for the species Gallus gallus, the domestic fowl, in the family Phasianidae, order GALLIFORMES. It is descended from the red jungle fowl of SOUTHEAST ASIA. Gallus gallus,Gallus domesticus,Gallus gallus domesticus,Chicken
D004734 Energy Metabolism The chemical reactions involved in the production and utilization of various forms of energy in cells. Bioenergetics,Energy Expenditure,Bioenergetic,Energy Expenditures,Energy Metabolisms,Expenditure, Energy,Expenditures, Energy,Metabolism, Energy,Metabolisms, Energy
D005230 Fatty Acids, Nonesterified FATTY ACIDS found in the plasma that are complexed with SERUM ALBUMIN for transport. These fatty acids are not in glycerol ester form. Fatty Acids, Free,Free Fatty Acid,Free Fatty Acids,NEFA,Acid, Free Fatty,Acids, Free Fatty,Acids, Nonesterified Fatty,Fatty Acid, Free,Nonesterified Fatty Acids
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Tetsuya Tachibana, and Daichi Oikawa, and Nami Adachi, and Tim Boswell, and Mitsuhiro Furuse
March 2002, British poultry science,
Tetsuya Tachibana, and Daichi Oikawa, and Nami Adachi, and Tim Boswell, and Mitsuhiro Furuse
June 2016, Current opinion in lipidology,
Tetsuya Tachibana, and Daichi Oikawa, and Nami Adachi, and Tim Boswell, and Mitsuhiro Furuse
February 2014, Peptides,
Tetsuya Tachibana, and Daichi Oikawa, and Nami Adachi, and Tim Boswell, and Mitsuhiro Furuse
May 2024, Diabetes & metabolism journal,
Tetsuya Tachibana, and Daichi Oikawa, and Nami Adachi, and Tim Boswell, and Mitsuhiro Furuse
March 2015, Animal science journal = Nihon chikusan Gakkaiho,
Tetsuya Tachibana, and Daichi Oikawa, and Nami Adachi, and Tim Boswell, and Mitsuhiro Furuse
January 2019, Zhonghua nei ke za zhi,
Tetsuya Tachibana, and Daichi Oikawa, and Nami Adachi, and Tim Boswell, and Mitsuhiro Furuse
January 2001, Pharmacology, biochemistry, and behavior,
Tetsuya Tachibana, and Daichi Oikawa, and Nami Adachi, and Tim Boswell, and Mitsuhiro Furuse
April 1997, Brain research,
Tetsuya Tachibana, and Daichi Oikawa, and Nami Adachi, and Tim Boswell, and Mitsuhiro Furuse
December 2004, Best practice & research. Clinical endocrinology & metabolism,
Tetsuya Tachibana, and Daichi Oikawa, and Nami Adachi, and Tim Boswell, and Mitsuhiro Furuse
April 2018, Current opinion in lipidology,
Copied contents to your clipboard!